This inventor holds 2 USPTO granted patents. Top assignee: Massachusetts Institute of Technology. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Helen L. Evans: Innovator in Cancer Research
Introduction
Helen L. Evans is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer research through her innovative work. With a total of 2 patents, her inventions focus on developing compounds that can potentially treat diseases associated with Myc.
Latest Patents
Helen's latest patents include "Max binders as MYC modulators and uses thereof." This patent provides compounds of various formulas that act as MAX binders and modulators of Myc, Mad, or Mxi1. These compounds may serve as inhibitors of Myc, Mad, or Mxi1, which are crucial in treating proliferative diseases such as cancer. The patent also details pharmaceutical compositions and kits that incorporate these compounds, along with methods for their use.
Career Highlights
Helen L. Evans is affiliated with the Massachusetts Institute of Technology, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and therapeutic strategies.
Collaborations
Some of her notable coworkers include Francisco Caballero and Nicholas B. Struntz, who contribute to her research endeavors.
Conclusion
Helen L. Evans stands out as an influential inventor in the realm of cancer research, with her innovative patents paving the way for new treatment options. Her contributions are vital in the ongoing fight against cancer and related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile